Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis.
about
Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosisInflammatory status in human hepatic cirrhosisInteractions between Myc and Mediators of Inflammation in Chronic Liver DiseasesThe wound healing, chronic fibrosis, and cancer progression triadHelicobacter hepaticus induces an inflammatory response in primary human hepatocytesEffect of ginseng extract on the TGF-β1 signaling pathway in CCl4-induced liver fibrosis in ratsNon-cell-autonomous tumor suppression by p53.A comparative multi-parametric in vitro model identifies the power of test conditions to predict the fibrotic tendency of a biomaterial.Gene expression signature for biliary atresia and a role for interleukin-8 in pathogenesis of experimental diseaseLicensing virus-specific T cells to secrete the neutrophil attracting chemokine CXCL-8 during hepatitis B virus infectionShotgun proteomics: identification of unique protein profiles of apoptotic bodies from biliary epithelial cellsElevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytesMonocyte subsets in human liver disease show distinct phenotypic and functional characteristicsThe peritoneal macrophage inflammatory profile in cirrhosis depends on the alcoholic or hepatitis C viral etiology and is related to ERK phosphorylation.Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients.Enhanced levels of interleukin-8 are associated with hepatitis B virus infection and resistance to interferon-alpha therapy.Senescent human hepatocytes express a unique secretory phenotype and promote macrophage migrationChronic alcohol exposure exacerbates inflammation and triggers pancreatic acinar-to-ductal metaplasia through PI3K/Akt/IKKInfluence of the CXCL1 rs4074 A allele on alcohol induced cirrhosis and HCC in patients of European descent.Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.Balance of inflammatory pathways and interplay of immune cells in the liver during homeostasis and injury.ERK2-dependent activation of c-Jun is required for nontypeable Haemophilus influenzae-induced CXCL2 upregulation in inner ear fibrocytes.The end-organ impairment in liver cirrhosis: appointments for critical care.Increased CD86 but Not CD80 and PD-L1 Expression on Liver CD68+ Cells during Chronic HBV Infection.Plasma levels of growth-related oncogene (CXCL1-3) associated with fibrosis and platelet counts in HCV-infected patients.Serum levels of inflammatory cytokines in Rift Valley fever patients are indicative of severe diseaseChemokine Receptor Expression on Normal Blood CD56(+) NK-Cells Elucidates Cell Partners That Comigrate during the Innate and Adaptive Immune Responses and Identifies a Transitional NK-Cell Population.Peripheral Blood Mononuclear Cell Gene Expression Remains Broadly Altered Years after Successful Interferon-Based Hepatitis C Virus TreatmentFunctional role of monocytes and macrophages for the inflammatory response in acute liver injury.Expression of inflammation-related genes is altered in gastric tissue of patients with advanced stages of NAFLD.Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical modelSelected Cytokines Serve as Potential Biomarkers for Predicting Liver Inflammation and Fibrosis in Chronic Hepatitis B Patients With Normal to Mildly Elevated Aminotransferases.The Distribution and the Fibrotic Role of Elevated Inflammatory Th17 Cells in Patients With Primary Biliary CirrhosisIdentification and expression profiles of IL-8 in bighead carp (Aristichthys nobilis) in response to microcystin-LR.Immune-mediated liver injury of the cancer therapeutic antibody catumaxomab targeting EpCAM, CD3 and Fcγ receptors.Experimental liver fibrosis research: update on animal models, legal issues and translational aspects.Hepatic SATB1 induces paracrine activation of hepatic stellate cells and is upregulated by HBx.Role of gut microbiota in liver diseases.Direct, interferon-independent activation of the CXCL10 promoter by NF-κB and interferon regulatory factor 3 during hepatitis C virus infection.A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse.
P2860
Q21560965-8C814C9B-87CA-40FE-85B6-2353C14EC064Q26778040-5ADB9ECF-1A7D-4BD3-B84B-A3C797D9812EQ26778328-F5961F10-8F04-49B4-B819-C6660E04C291Q27014616-D0C2D42A-F882-45F0-AA8C-E189038D94EBQ27323910-378DEBF3-7D9B-4005-8CF5-6E225AA636B9Q28468606-F7B864D1-A560-40CF-81B7-7C2F95788909Q30541182-EBB03F86-A2B0-4CF4-9623-9802B3F08E7BQ33687188-9798DBCB-0515-4CC8-8B75-0FF723056279Q33831666-A43EB616-E3C9-42F9-A904-5A7E7A1829E3Q34005464-750F5967-0032-4742-B769-AEF12BE47712Q34243335-9F40B903-9716-4894-A089-87AA028C88CDQ34244205-BA9866B6-1061-482C-9B5B-DE538A357A70Q34326022-60E25E98-6AB1-48BD-BC8F-BBE0C3BF6CECQ34367509-EE349FA9-6D64-47E1-8E34-04E89A464DABQ34673075-21611696-40FB-4373-9061-21E765DB9A34Q34685727-38F9B44B-1C20-43DD-A5EA-FABA417874C9Q34750592-3DA8FBB5-C49D-4F52-AD8B-788450D64E45Q35040048-C452E7EF-30A9-4BC8-931F-D2B5B48A6390Q35049299-9AB3F74E-A972-4F5A-A339-57F05ADF4751Q35622533-E4ADDFBE-2CBE-47BA-BDDC-0ABA7E52B1ABQ35728941-0587A0D4-6755-44FF-97F3-74D39D005A63Q35850886-AB5BC95A-4A1E-41C4-86B7-47F18776274DQ35993701-8B19A479-0D0C-45DB-8B64-64984D1AA757Q36062362-A2CB2988-7453-4410-A5E6-B61CB8120CAEQ36118056-61730CAA-591F-4AD5-A8F7-A69913E22C9CQ36127490-9EE57F98-82A0-4DA3-B572-DE1A3484A7C8Q36205360-67E998CE-2E63-4DEC-82AD-6554F36E7D50Q36237433-8389FCD8-1B98-49E0-8337-FF53E61C114BQ36331567-FF22C042-056D-4873-9B9C-E546A5F8D9D8Q36764856-1D298EEA-0108-4B50-8D2E-5C8B06E36869Q36815018-B4793D06-0734-4B15-84D3-2F992956F441Q37016751-87108D26-8930-4612-8FD9-72C22C3FEB96Q37026138-AEF57BB5-9DA4-4052-A1C8-66D7A0B74050Q37147519-7A536376-91C5-4990-AEAB-61C8F5B10470Q37317487-CA3ABD79-DCBC-4755-845C-6BDAA23D3664Q37363773-7E84046E-CE75-4AC0-A693-72A9E4C549E3Q37435158-54845DB7-E959-42C1-921A-951313640047Q37488165-97B19431-9C0C-4F03-B673-2FD00EE0FBD0Q37547206-B7B914D8-8147-4AA9-BDDE-6A1887C847E4Q37649853-66E66FC5-6846-4E9E-AF1C-EDD502C3D890
P2860
Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Interleukin-8 is activated in ...... ation in human liver fibrosis.
@ast
Interleukin-8 is activated in ...... ation in human liver fibrosis.
@en
type
label
Interleukin-8 is activated in ...... ation in human liver fibrosis.
@ast
Interleukin-8 is activated in ...... ation in human liver fibrosis.
@en
prefLabel
Interleukin-8 is activated in ...... ation in human liver fibrosis.
@ast
Interleukin-8 is activated in ...... ation in human liver fibrosis.
@en
P2093
P2860
P1433
P1476
Interleukin-8 is activated in ...... ation in human liver fibrosis.
@en
P2093
Christian Trautwein
Frank Tacke
Henning W Zimmermann
Jacob Nattermann
Nikolaus Gassler
Sebastian Seidler
Tom Luedde
P2860
P304
P356
10.1371/JOURNAL.PONE.0021381
P407
P577
2011-06-22T00:00:00Z